Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Increased wall ...

A report from the World Heart Federation provides an overview of transthyretin amyloid cardiomyopathy (ATTR-CM), including tools for diagnosis and patient management, highlighting the importance of ...

Reston, VA—A new study has determined that approximately three percent of all bone scan patients have markers of cardiac amyloidosis, which can lead to heart failure and increased mortality. Published ...

Appropriate use criteria (AUC) for bone scintigraphy to aid in the diagnosis of bone metastases in cancer patients have been issued by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in ...

Scoring tools validated to identify people at high risk of having transthyretin amyloid cardiomyopathy (ATTR-CM) still leave room for improvement in diverse populations. The ATTR-CM score and the ...

Bone scintigraphy is a widely accepted method for the evaluation of paediatric bone metabolism. Its strengths are high sensitivity and the capability to investigate the entire skeleton in a single ...